Is Elevance Health Inc (ELV) undervalued? · P/E 18, rev $199.13B
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
This page asks whether Elevance Health Inc (ELV) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new ELV 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare ELV to the stock page model before you treat a low multiple as a gift.
Not investment advice.